W. Reinisch

Publication List Details

Period

1992 - 2007

Number

11

Co-Authors

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (2006)

Reinisch, W., Hommes, D.W., Assche, G. Van, Colombel, J.F., Gendre, J.P., Oldenburg, B., ...

Introduction: This study was designed to evaluate the safety of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (CD). Patients and...

The value of serologic markers in indeterminate colitis: A prospective follow-up study - Reply (2003)

Joossens, S, Vermeire, SV, Reinisch, W, Colombel, JF, Rutgeerts, P, VAN STEEN, Kristel

Univ Hosp Gasthuisberg, Gastroenterol Unit, B-3000 Louvain, Belgium. Limburgs Univ Ctr, Ctr Stat, Diepenbeek, Belgium. Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria. CHRU Lille,...

The value of serologic markers in indeterminate colitis: A prospective follow-up study - Reply (2003)

Joossens, S, Vermeire, SV, Reinisch, W, Colombel, JF, Rutgeerts, P, VAN STEEN, Kristel

Univ Hosp Gasthuisberg, Gastroenterol Unit, B-3000 Louvain, Belgium. Limburgs Univ Ctr, Ctr Stat, Diepenbeek, Belgium. Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria. CHRU Lille,...

Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease

Reinisch, W, Heider, K, Oberhuber, G, Dejaco, C, Mullner, M, Adolf, G, ...

a Department of Clinical Pharmacology, b Clinic of Internal Medicine IV, Department of Gastroenterology and Hepatology, c Clinic of Pathology, d Department of Emergency Medicine, University of...

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

Tilg, H, Vogelsang, H, Ludwiczek, O, Lochs, H, Kaser, A, Colombel, J-F, ...

Background: Pilot studies of interferon α (IFN-α) suggest a high remission rate in the treatment of active ulcerative colitis. We evaluated the safety of pegylated interferon α (PegIFN) and its...

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Miehsler, W, Reinisch, W, Valic, E, Osterode, W, Tillinger, W, Feichtenschlager, T, ...

Background: Patients with inflammatory bowel disease (IBD) are thought to be at increased risk of venous thromboembolism (TE). However, the extent of this risk is not known. Furthermore, it is not...

Donor dependent, interferon-γ induced HLA-DR expression on human neutrophils in vivo

REINISCH, W, LICHTENBERGER, C, STEGER, G, TILLINGER, W, SCHEINER, O, GANGL, A, ...

Neutrophils are effector cells of innate immune responses. Stimulated by interferon-γ (IFN-γ) to express HLA-DR, neutrophils acquire accessory cell functions for superantigen-mediated T cell...